In the process, it became the highest-funded campaign in the site’s history. What made it so attractive is was its simplicity—and the fact that nothing like it exists.

Today, the company announced that it has raised a further $10.5 million in venture capital funding. More importantly, it said it will start clinical trials in early 2014, an important step on the way to being approved by America’s Food and Drug Administration (FDA).